Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2026 Earnings Call Transcript January 21, 2026
Dr. Reddy’s Laboratories Limited reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
Aishwarya Sitharam: Good day, everyone, and welcome to the Quarter 3 FY ’26 Earnings Call of Dr. Reddy’s Laboratories Limited. We appreciate your continued interest in our company. I’m Aishwarya Sitharam, Head of Investor Relations at Dr. Reddy’s. Joining us today are...
